Mangoceuticals Inc (MGRX)

Recent insider activity at Mangoceuticals Inc. includes several sell transactions and proposed sales by CFO Eugene M. Johnston and Director Alex P. Hamilton, primarily in December 2025 and November 2025. The most recent trading activity occurred on December 15, 2025. A significant buy transaction by CEO Jacob D. Cohen was noted on April 10, 2023.
Stock chart
Ticker: MGRX Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
JOHNSTON EUGENE M
CFO
1 sale — total 3,884 USD
Sale 15 Dec 2025
Value US$1,034,637.51 | Price 233.28 | Shares 57,051
Sale 9 Dec 2025
Value US$4,386,435.36 | Price 96.70 | Shares 90,963
Sale 5 Dec 2025
Value US$11,280.00 | Price 1.13 | Shares 10,000
Proposed sale 3 Dec 2025
Value US$148,866.28 | Price 1.16 | Shares 128,333
Sale 19 Nov 2025
Value US$152,875.00 | Price 1.22 | Shares 125,000
Proposed sale 19 Nov 2025
Value US$155,125.00 | Price 1.24 | Shares 125,000
Sale 26 Jun 2024
Value US$34,696.32 | Price 0.32 | Shares 108,426
Sale 25 Jun 2024
Value US$5,137.94 | Price 0.31 | Shares 16,574
Proposed sale 21 Jun 2024
Value US$52,500.00 | Price 0.35 | Shares 150,000
Proposed sale 21 Jun 2024
Value US$52,500.00 | Price 0.35 | Shares 150,000
Proposed sale 21 Jun 2024
Value US$15,000.00 | Price 0.30 | Shares 50,000
Proposed sale 10 Jun 2024
Value US$21,500.00 | Price 0.43 | Shares 50,000
Buy 10 Apr 2023
Value US$275,000.00 | Price 1.00 | Shares 275,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-17 2025-12-15 S Sale

CFO

Officer
57,051 +19.5%
233.28
US$1,034,638
57,051 +19.5% 233.28 US$1,034,638
2025-12-11 2025-12-09 S Sale

CFO

Officer
90,963 -40.6%
96.70
US$4,386,435
90,963 -40.6% 96.70 US$4,386,435
2025-12-09 2025-12-05 S Sale

CFO

Officer
58,405 -42.6%
421.62
US$4,390,708
58,405 -42.6% 421.62 US$4,390,708
2025-12-03 2025-12-03 PrS Proposed sale

Officer

Officer
128,333
1.16
US$148,866
128,333 1.16 US$148,866
2025-11-26 2025-11-19 S Sale Non-Executive Director
125,000 -97.4%
1.22
US$152,875
125,000 -97.4% 1.22 US$152,875
2025-11-19 2025-11-19 PrS Proposed sale

Director

Non-Executive Director
125,000
1.24
US$155,125
125,000 1.24 US$155,125
2024-06-27 2024-06-26 S Sale Non-Executive Director
108,426 -68.4%
0.32
US$34,696
108,426 -68.4% 0.32 US$34,696
2024-06-27 2024-06-25 S Sale Non-Executive Director
16,574 -9.5%
0.31
US$5,138
16,574 -9.5% 0.31 US$5,138
2024-06-24 2024-06-21 PrS Proposed sale

Board of Director

Non-Executive Director
150,000
0.35
US$52,500
150,000 0.35 US$52,500
2024-06-20 2024-06-21 PrS Proposed sale

Board Member

150,000
0.35
US$52,500
150,000 0.35 US$52,500
2024-06-18 2024-06-21 PrS Proposed sale

Board of Directors

Non-Executive Director
50,000
0.30
US$15,000
50,000 0.30 US$15,000
2024-06-10 2024-06-10 PrS Proposed sale

Self

50,000
0.43
US$21,500
50,000 0.43 US$21,500
2023-05-02 2023-04-10 B Purchase

Chief Executive Officer

Executive Director Large shareholder
275,000 +3.4%
1.00
US$275,000
275,000 +3.4% 1.00 US$275,000